|
CN112034078A
|
|
Method for detecting carbamazepine
|
|
CN111929394A
|
|
Warfarin detection method
|
|
CN111812260A
|
|
Detection method of vitamin B2
|
|
CN111830179A
|
|
Detection method of pyridoxal 5-phosphate
|
|
CN111693635A
|
|
Method for detecting rapamycin content in blood
|
|
CN111830178A
|
|
Method for detecting glutathione
|
|
CN111830177A
|
|
Method for detecting clonazepam
|
|
CN111679023A
|
|
Method for detecting mycophenolic acid content in blood
|
|
CN111394442A
|
|
Method for synchronously detecting mutation of No. 8, 19, 20 and 21 exon genes of ERBB2 gene
|
|
CN111334582A
|
|
Method for synchronously detecting 4 exon gene mutations of P53 gene
|
|
CN111518888A
|
|
Method for synchronously detecting gene polymorphism of two SNP sites of APOE gene
|
|
CN111363806A
|
|
Primer group for detecting vitamin B12 metabolic gene mutation and application method thereof
|
|
CN111500727A
|
|
Primer group for detecting KRAS gene and BRAF gene mutation and application method thereof
|
|
CN111471656A
|
|
Stable transfer cell strain for detecting NMO-IgG and construction method thereof
|
|
CN111534591A
|
|
Method for synchronously detecting gene polymorphism of two SNP sites of UGT1A1 gene
|
|
CN111518901A
|
|
Primer group for detecting EGFR gene mutation and application method thereof
|
|
CN111500726A
|
|
Primer group for detecting pathogenic gene mutation of pheochromocytoma and paraganglioma and application method thereof
|
|
CN111518887A
|
|
Primer group, kit and method for detecting HLA-B1502 allele
|
|
CN111394441A
|
|
Primer group, kit and method for amplification of vitamin A related gene
|
|
CN111394468A
|
|
Primer group for detecting BRCA gene mutation and application method thereof
|
